Suofeng Sun
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Hepatitis B Virus Studies 7
-
- Circular RNAs in diseases 3
- Co-authors
- Xiuling Li (13 shared papers)Shuangyin Han (9 shared papers)Bingyong Zhang (6 shared papers)Bowei Liu (6 shared papers)Xiaoying Luo (6 shared papers)Yuan Li (3 shared papers)Zhen Li (3 shared papers)Xiuling Li (4 shared papers)
In The Last Decade
Suofeng Sun
25 papers receiving 548 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 201
- Hepatology 75
- Molecular Biology 279
- Epidemiology 123
- Pulmonary and Respiratory Medicine 71
Countries citing papers authored by Suofeng Sun
This map shows the geographic impact of Suofeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suofeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suofeng Sun more than expected).
Fields of papers citing papers by Suofeng Sun
This network shows the impact of papers produced by Suofeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suofeng Sun. The network helps show where Suofeng Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Suofeng Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 66 | |
| 2 | Circular RNA circ-ADD3 inhibits hepatocellular carcinoma metastasis through facilitating EZH2 degradation via CDK1-mediated ubiquitination. | 2019 | 60 |
| 3 | 2020 | 52 | |
| 4 | 2020 | 50 | |
| 5 | 2019 | 44 | |
| 6 | 2021 | 40 | |
| 7 | 2018 | 35 | |
| 8 | 2021 | 33 | |
| 9 | 2019 | 23 | |
| 10 | 2017 | 23 | |
| 11 | 2016 | 22 | |
| 12 | 2019 | 20 | |
| 13 | 2019 | 18 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 12 | |
| 16 | 2022 | 11 | |
| 17 | 2022 | 7 | |
| 18 | 2020 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2018 | 3 |
About Suofeng Sun
Suofeng Sun is a scholar working on Epidemiology, Molecular Biology, Hepatology, Oncology and Cancer Research, having authored 27 papers that have together received 552 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (5 papers), Ferroptosis and cancer prognosis (3 papers), Liver physiology and pathology (3 papers), Circular RNAs in diseases (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related molecular mechanisms research (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Cancer Research (201 citations), Hepatology (75 citations), Molecular Biology (279 citations), Epidemiology (123 citations) and Pulmonary and Respiratory Medicine (71 citations). Suofeng Sun has collaborated with scholars based in China, Japan and Hong Kong. Frequent co-authors include Xiuling Li, Shuangyin Han, Bingyong Zhang, Bowei Liu, Xiaoying Luo, Yuan Li, Zhen Li, Xiuling Li, Zhiyu Yang and Jian Li. Their work appears in journals such as OncoTargets and Therapy, Scientific Reports, Cell Death and Disease, Cell Proliferation and Archives of Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.